Gilder Gagnon Howe & Co’s Molecular Templates, Inc. MTEM Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,436	Closed	-$1.6M	–	445
2021 Q1	$1.6M	Sell	8,436 -185	-2%	-$32.4K	0.01%	288
2020 Q4	$1.21M	Sell	8,621 -25,656	-75%	-$3.79M	0.01%	261
2020 Q3	$5.62M	Sell	34,277 -268	-0.8%	-$47.6K	0.03%	190
2020 Q2	$7.15M	Sell	34,545 -13,494	-28%	-$3.14M	0.06%	163
2020 Q1	$9.58M	Sell	48,039 -15,722	-25%	-$3.44M	0.11%	125
2019 Q4	$13.4M	Sell	63,761 -651	-1%	-$93.6K	0.14%	121
2019 Q3	$6.37M	Sell	64,412 -849	-1%	-$79.2K	0.07%	150
2019 Q2	$8.17M	Sell	65,261 -39	-0.1%	-$4.24K	0.08%	136
2019 Q1	$5.69M	Sell	65,300 -813	-1%	-$59.6K	0.06%	157
2018 Q4	$4.01M	Sell	66,113 -1,151	-2%	-$80.3K	0.06%	167
2018 Q3	$5.44M	Buy	+67,264	New	+$5.16M	0.06%	171

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Gilder Gagnon Howe & Co's MTEM Position: Q2 2021 in Review

Gilder Gagnon Howe & Co sold out of Molecular Templates, Inc. (MTEM) in Q2 2021, closing a stake of 8,436 shares — an estimated $1.6M sold.

Gilder Gagnon Howe & Co first reported a position in MTEM in Q3 2018 and held it in 11 quarters. The position peaked at $13.4M in Q4 2019. 89 funds tracked by Wall St. Rank hold MTEM as of Q2 2021.

Gilder Gagnon Howe & Co reported no remaining Molecular Templates, Inc. position as of Q2 2021 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 8,436 Molecular Templates, Inc. shares in Q2 2021, an estimated $1.6M.
Gilder Gagnon Howe & Co first reported a position in Molecular Templates, Inc. in Q3 2018 and held it in 11 quarters.
Gilder Gagnon Howe & Co's Molecular Templates, Inc. position peaked at $13.4M in Q4 2019.
89 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2021, filed 16 Aug 2021.